Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer : In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5.
Dirk BoehmerArne GrünPublished in: Current oncology reports (2021)
We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5 . We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports.
Keyphrases
- muscle invasive bladder cancer
- neoadjuvant chemotherapy
- locally advanced
- palliative care
- adverse drug
- rectal cancer
- squamous cell carcinoma
- lymph node
- radiation therapy
- sentinel lymph node
- biofilm formation
- randomized controlled trial
- pseudomonas aeruginosa
- radiation induced
- emergency department
- escherichia coli
- staphylococcus aureus
- meta analyses
- candida albicans